MedTrace Logo

Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion

NCT00073554 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2009-12-17

No results posted yet for this study

Summary

This trial is for patients with acute occlusion of one of the arteries supplying blood to the leg. The trial is designed to determine the safety and activity of a novel clot dissolving (thrombolytic) drug (alfimeprase).

Conditions

  • Arterial Occlusive Diseases
  • Peripheral Vascular Diseases
  • Thrombosis

Interventions

DRUG

Alfimeprase

Sponsors & Collaborators

  • Premier Research

    collaborator OTHER

  • ARCA Biopharma, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00073554 on ClinicalTrials.gov